Laurus Labs Limited receives EIR for API facility Unit-4

Laurus Labs Limited has received the Establishment Inspection Report (EIR), pursuant to the inspection conducted by the United States Food & Drug Administration (USFDA) at our API manufacturing facility Unit-4, Atchutapuram, Anakapalli District (Visakhapatnam), Andhra Pradesh from 27th January, 2025 to 31st January, 2025.

Shares of Laurus Labs Limited was last trading in BSE at Rs. 606.10 as compared to the previous close of Rs. 563.40. The total number of shares traded during the day was 156659 in over 9267 trades.

The stock hit an intraday high of Rs. 608.05 and intraday low of 570.20. The net turnover during the day was Rs. 93447588.00.

Source : Equity Bulls

Keywords

LaurusLabs INE947Q01028 Pharmaceuticals USFDA Inspection EIR Unit4 APIManufacturingFacility Atchutapuram